Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T D'Aquila

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Virology|July 1, 1989
Physical mapping of the human cytomegalovirus (HCMV) (Towne) DNA polymerase gene: DNA-mediated transfer of a genetic marker for an HCMV geneR T D'Aquila, G S Hayward, W C Summers
Virology|June 12, 1999
Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 polH F Günthard, A J Leigh-Brown, R T D'Aquila, et al.
Journal of Virology|April 10, 1999
Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1J Martinez-Picado, A V Savara, L Sutton, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1992
Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolatesJ J Eron, P Gorczyca, J C Kaplan, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Race/ethnicity as a risk factor for HIV-1 infection among Connecticut intravenous drug usersR T D'Aquila, L R Peterson, A B Williams, et al.
AIDS Care|January 1, 1992
Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug usersA B Williams, E A McNelly, A E Williams, et al.
The Journal of Infectious Diseases|June 2, 1998
CCR5/delta(ccr5) heterozygosity: a selective pressure for the syncytium-inducing human immunodeficiency virus type 1 phenotype. NIAID AIDS Clinical Trials Group Protocol 241 Virology TeamR T D'Aquila, L Sutton, A Savara, et al.
Virology|September 22, 2000
Fitness of human immunodeficiency virus type 1 protease inhibitor-selected single mutantsJ Martinez-Picado, A V Savara, L Shi, et al.
Journal of Virology|April 1, 1996
Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replicationA M Caliendo, A Savara, D An, et al.
Journal of Clinical Microbiology|August 17, 1999
Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testingJ Martinez-Picado, L Sutton, M P De Pasquale, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Virology|July 1, 1989
Physical mapping of the human cytomegalovirus (HCMV) (Towne) DNA polymerase gene: DNA-mediated transfer of a genetic marker for an HCMV geneR T D'Aquila, G S Hayward, W C Summers
Virology|June 12, 1999
Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 polH F Günthard, A J Leigh-Brown, R T D'Aquila, et al.
Journal of Virology|April 10, 1999
Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1J Martinez-Picado, A V Savara, L Sutton, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1992
Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolatesJ J Eron, P Gorczyca, J C Kaplan, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Race/ethnicity as a risk factor for HIV-1 infection among Connecticut intravenous drug usersR T D'Aquila, L R Peterson, A B Williams, et al.
AIDS Care|January 1, 1992
Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug usersA B Williams, E A McNelly, A E Williams, et al.
The Journal of Infectious Diseases|June 2, 1998
CCR5/delta(ccr5) heterozygosity: a selective pressure for the syncytium-inducing human immunodeficiency virus type 1 phenotype. NIAID AIDS Clinical Trials Group Protocol 241 Virology TeamR T D'Aquila, L Sutton, A Savara, et al.
Virology|September 22, 2000
Fitness of human immunodeficiency virus type 1 protease inhibitor-selected single mutantsJ Martinez-Picado, A V Savara, L Shi, et al.
Journal of Virology|April 1, 1996
Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replicationA M Caliendo, A Savara, D An, et al.
Journal of Clinical Microbiology|August 17, 1999
Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testingJ Martinez-Picado, L Sutton, M P De Pasquale, et al.
Pageof 7